Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results

被引：1

作者：

Laccetti, A. L. ^{[1
]}

Chatta, G. ^{[2
]}

Kyriakopoulos, C. ^{[3
]}

Iannotti, N. ^{[4
]}

Hotte, S. J. ^{[5
]}

Markowski, M. C. ^{[6
]}

Pili, R. ^{[7
]}

Vuky, J. ^{[8
]}

Zhang, J. ^{[9
]}

Saad, F. ^{[10
]}

Villaluna, K. ^{[11
]}

Younginger, B. ^{[11
]}

Le Moigne, R. ^{[11
]}

Cesano, A. ^{[11
]}

机构：

[1] MSKCC Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, Dept Med, New York, NY USA

[2] Roswell Pk Comprehens Canc Ctr, Oncol Dept, Buffalo, NY USA

[3] UW, Hematol Oncol, Carbone Canc Ctr, Madison, WI USA

[4] Hematol Oncol Associates Treasure Coast, Oncol Dept, Ft Pierce, FL USA

[5] JCC Juravinski Canc Ctr Hamilton Hlth Sci, Oncol Dept, Hamilton, ON, Canada

[6] Johns Hopkins Sidney Kimmel Canc Ctr, Oncol Dept, Baltimore, MD USA

[7] SUNY Buffalo, Clin & Translat Res Ctr, Med Dept, Buffalo, NY USA

[8] OHSU, Div Hematol & Med Oncol, Knight Canc Inst, Ctr Hlth & Healing Bldg 2, Portland, OR USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Genito Urinary, Magnolia Campus, Tampa, FL USA

[10] Hosp St Luc CHUM, Urol Dept, Montreal, PQ, Canada

[11] ESSA Pharmaceut Corp, Clin Dpt, San Francisco, CA USA

来源：

关键词：

D O I：

10.1016/j.annonc.2023.09.2761

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1813P

引用

页码：S982 / S983

页数：2